Showing 7061-7070 of 20895 results for "".
- New Consensus Statement for Diagnosis of Atypical Parkinsonian Disorders Publishedhttps://reachmd.com/news/new-consensus-statement-for-diagnosis-of-atypical-parkinsonian-disorders-published/2468184/A recent consensus statement published in Neurology Clinical Practice provides a differential diagnosis algorithm that may be helpful for use by general neurologists who are seeing patients with a potential atypical parkinsonian disorder (APD). The statement includes an
- Machine Learning May Lead to Better Flu Vaccineshttps://reachmd.com/news/machine-learning-may-lead-to-better-flu-vaccines/2468143/NIAViD is a model for detecting antigenic transitions in influenza A (H3N2) without knowledge of cluster identity. This figure illustrates the computational workflow used to fit and valid
- Studies Provide First Evidence That Breastfeeding After Breast Cancer Is Safehttps://reachmd.com/news/studies-provide-first-evidence-that-breastfeeding-after-breast-cancer-is-safe/2468145/Two international studies presented at the ESMO Congress 2024 show no increase in recurrence or new breast cancers in women who breastfeed after being treated for breast cancer. Results provide the first evidence that breastfeeding after breast cancer is feasible and safe
- Pediatricians Highlight Role of ACIP During COVID-19 Pandemichttps://reachmd.com/news/pediatricians-highlight-role-of-acip-during-covid-19-pandemic/2468144/BYLINE: Myra Wright Key takeaways:Virtual meeting format allowed emergency meetings to be quickly scheduled and enabled members of the public to attend.Efforts should always be made to include diverse populations in
- UMass Amherst Researcher to Use Wearable Sleep Trackers, AI to Predict Early Signs of Alzheimer’shttps://reachmd.com/news/umass-amherst-researcher-to-use-wearable-sleep-trackers-ai-to-predict-early-signs-of-alzheimers/2468142/The National Institutes of Health has awarded Joyita Dutta, professor of biomedical engineering at the University of Massachusetts Amherst, $3.9 million over five years to study if wearable sleep trackers can predict blo
- Can Chatbots Help with Genetic Testing for Cancer Risk?https://reachmd.com/news/can-chatbots-help-with-genetic-testing-for-cancer-risk/2468148/In a study from Huntsman Cancer Institute at the
- Zongertinib Demonstrates Promising Efficacy in Patients with HER2-Mutant Non-Small Cell Lung Cancerhttps://reachmd.com/news/zongertinib-demonstrates-promising-efficacy-in-patients-with-her2-mutant-non-small-cell-lung-cancer/2468153/by International Association for the Study of Lung Cancer
- Zynex Obtains FDA Clearance for New Pain Management Devicehttps://reachmd.com/news/zynex-obtains-fda-clearance-for-new-pain-management-device/2468118/ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI),
- Evernorth Announces Another Step Forward in Lowering Drug Prices by Making a Stelara Biosimilar Available at $0 Out of Pocket for Patients Early Next Yearhttps://reachmd.com/news/evernorth-announces-another-step-forward-in-lowering-drug-prices-by-making-a-stelara-biosimilar-available-at-0-out-of-pocket-for-patients-early-next-year/2468119/BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025. The interchangeable biosimilar will be produced for Eve
- Penn Research Uncovers Key Biomarker for Diagnosing Sarcoidosishttps://reachmd.com/news/penn-research-uncovers-key-biomarker-for-diagnosing-sarcoidosis/2468124/Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease. It's nicknamed "the great mimicker," because it